A Beautiful Movie About People With MS — and We’re In It

My dear friend, Kate Milliken, called me a few months ago to see if I would be part of a short documentary she was co–producing with David Kuhn from the esteemed Nantucket Project. The film would be funded by a grant from the Swiss pharmaceutical company, Novartis. “Yes.” “Don’t you want to know the details… Continue reading A Beautiful Movie About People With MS — and We’re In It

Dispatches from CoronaVille – Post #3 – View from the Apex

The people who study such things have concluded that most of the United States is at or near the apex of this coronavirus pandemic. Life at the apex is a duality. The following two statements, it could be argued, are equally correct:  “Things have never been worse,” or  “Things should only get better from here.” … Continue reading Dispatches from CoronaVille – Post #3 – View from the Apex

Man versus Coronavirus

If you’re looking for updated information on the spread of the coronavirus, or medical advice about how it might affect people with MS, or restrained commentary of any kind, this is not the post for you. If you want an irreverent account of how the threat of the coronavirus is affecting one man with MS, keep… Continue reading Man versus Coronavirus

I Am Helping With the Novartis Innovation Prize

Novartis is offering a $250,000 prize to fund the development of pioneering innovation with great potential in advancing Assistive Tech for Multiple Sclerosis. Applications will be accepted until January 10, 2020, and the winners will be announced during a panel discussion among experts in the field at SXSW in Austin, Texas. As many of you… Continue reading I Am Helping With the Novartis Innovation Prize

2019 Annual Report

Eighteen years is a long time to have had MS. Unimpressed by that number? How about the fact that I’ve lived with MS for upwards of five billion seconds, and I haven’t taken a single one of them off? Welcome to my Annual Report post where I consider what I’ve gained and lost in the… Continue reading 2019 Annual Report